JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB16661

Anti-Progesterone Receptor antibody [SP2]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Advanced Validation
  • Recombinant
  • What is this?

4

(4 Reviews)

|

(49 Publications)

Anti-Progesterone Receptor antibody [SP2] (ab16661) is a rabbit monoclonal antibody detecting Progesterone Receptor in Flow Cytometry, IHC-P, ICC/IF, mIHC. Suitable for Human.

- Multiplex IHC validated on the Leica BOND® MAX using Opal reagents
- Biophysical QC for unrivalled batch-batch consistency
- Over 40 publications
- Trusted since 2005

View Alternative Names

NR3C3, PGR, Progesterone receptor, PR, Nuclear receptor subfamily 3 group C member 3

8 Images
Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • mIHC

Supplier Data

Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human triple-positive breast carcinoma tissue sections labeling Progesterone Receptor (PR) with ab16661, at a 1/6000 dilution ( 0.2 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain. Panel A : merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human triple-positive breast carcinoma. Panel B : anti-PR stained on nucleus of cancer cells. Panel C : anti-HER2 stained on membrane of cancer cells. Panel D : anti-ER stained on nucleus of cancer cells. The section was incubated in three rounds of staining : in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Flow Cytometry analysis of T-47D (human ductal breast epithelial tumor epithelial cell) cells labeling Progesterone Receptor with purified ab16661 at 1/220 dilution (1.04 μg/ml) - Red. Cells were fixed with 4% paraformaldehyde . A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1 : 2000 dilution. Isotype control - Rabbit monoclonal IgG (ab172730) - Black. Unlabeled control - Blue.

This image was generated from the hybridoma version.

Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Overlay histogram showing T47D cells stained with ab16661 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab16661 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5000 events was performed.

This image was generated from the hybridoma version.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Immunohistochemistry analysis of human breast carcinoma tissue labelling SP2 with ab16661.

This image was generated from the hybridoma version.

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Immunocytochemistry/ Immunofluorescence analysis of T-47D (human ductal breast epithelial tumor epithelial cell) cells labeling Progesterone Receptor with purified ab16661 at 1/100 (2.28 μg/ml). Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

This image was generated from the hybridoma version.

Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • mIHC

Supplier Data

Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human mammary gland tissue sections labeling Progesterone Receptor (PR) with ab16661, at a 1/6000 dilution ( 0.2 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain. Panel A : merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human mammary gland. Panel B : anti-PR stained on nucleus of some ductal cells. Panel C : anti-HER2 stained on no cells. Panel D : anti-ER stained on nucleus of some ductal cells. The section was incubated in three rounds of staining : in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • mIHC

Supplier Data

Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human triple-negative breast carcinoma tissue sections labeling Progesterone Receptor (PR) with ab16661, at a 1/6000 dilution ( 0.2 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain. Panel A : merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human triple-negative breast carcinoma. Panel B : anti-PR stained on no cells. Panel C : anti-HER2 stained on no cells. Panel D : anti-ER stained on no cells. The section was incubated in three rounds of staining : in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (AB16661)
  • ICC/IF

PubMed

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (AB16661)

Rat mammary epithelial cells stained for Pr (pink) using ab16661 at 1/100 dilution in ICC/IF.

Ding L, et al. (2019), PLOS Genetics, 15(3), e1008002. Fig 3D, DOI: 10.1371/journal.pgen.1008002. Reproduced under the Creative Commons licence. https://creativecommons.org/licenses/by/4.0/

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Progesterone Receptor antibody [SP2]

  • Carrier free

    Anti-Progesterone Receptor antibody [SP2] - BSA and Azide free

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Progesterone Receptor antibody [SP2]

  • Unconjugated

    Anti-Progesterone Receptor antibody [SP2], prediluted

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

SP2

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, mIHC, Flow Cyt, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "mIHC" : {"fullname" : "Multiplex immunohistochemistry", "shortname":"mIHC"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "mIHC-species-checked": "testedAndGuaranteed", "mIHC-species-dilution-info": "1/6000", "mIHC-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/100", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/400", "IHCP-species-notes": "<p>Staining of formalin-fixed tissues is required by boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at RT for 20 min.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" }, "Rat": { "mIHC-species-checked": "predicted", "mIHC-species-dilution-info": "", "mIHC-species-notes": "", "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-Progesterone Receptor antibody [SP2] (ab16661) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), Multiplex IHC (mIHC) in Human samples.

Collaboration
Anti-Progesterone Receptor [SP2] (ab16661) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC).

Trusted by the scientific community
Anti-Progesterone Receptor [SP2] (ab16661) was first used in a scientific publication in 2005 and has been cited over 40 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [SP2] also available for your convenience: ab16661, ab27596, Carrier free - ab239793, Alexa Fluor® 488 - ab267523, Alexa Fluor® 647 - ab267524

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The progesterone receptor (PR) also known as NR3C3 is a nuclear receptor that functions as a transcription factor in response to the hormone progesterone. This receptor has a mass of approximately 99 kDa and is expressed in tissues such as the reproductive organs including the uterus ovaries and mammary glands. It is also found in non-reproductive tissues like the brain and bone. The receptor has two main isoforms PR-A and PR-B which differ slightly in structure but have unique biological roles.
Biological function summary

The progesterone receptor plays a significant role in regulating gene expression related to reproductive processes. PR is not part of a larger complex by itself but interacts with various coactivators and corepressors to modulate transcription. In the uterus and mammary glands PR mediates the effects of progesterone by promoting cell proliferation and preparing tissues for pregnancy. In other systems PR also links to various metabolic and immunological pathways influencing cell cycle progression and immune response.

Pathways

Progesterone receptor activity is integrated within the reproductive hormone signaling pathways and the Wnt signaling pathway. The receptor interacts directly with key proteins such as estrogen receptor (ER) and steroid receptor coactivator (SRC) complexes which are pivotal in modulating response to hormonal signals. These interactions underline the essential role of PR in maintaining hormonal balance and regulating reproductive functions.

The progesterone receptor associates with breast cancer and endometriosis. Aberrant expression or mutations in PR can contribute to the development and progression of breast cancer often linked with the estrogen receptor's influence. In endometriosis PR's altered functionality affects cellular response to progesterone contributing to tissue growth outside the uterus. These conditions also involve interactions with proteins like BRCA1 in breast cancer highlighting how PR connects to broader cellular and pathological networks.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as a transcriptional activator or repressor.. Isoform A. Ligand-dependent transdominant repressor of steroid hormone receptor transcriptional activity including repression of its isoform B, MR and ER. Transrepressional activity may involve recruitment of corepressor NCOR2.. Isoform B. Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation.. Isoform 4. Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
See full target information PGR

Publications (49)

Recent publications for all applications. Explore the full list and refine your search

Veterinary sciences 12: PubMed40284805

2025

Effects of Ladder-Climbing Exercise on Mammary Cancer: Data from a Chemically Induced Rat Model.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica Silva,Tiago Azevedo,Inês Aires,Catarina Medeiros,Maria J Neuparth,Fernanda Seixas,Rita Ferreira,Ana I Faustino-Rocha,Paula A Oliveira,José Alberto Duarte

Reproductive biology and endocrinology : RB&E 23:47 PubMed40140889

2025

A novel senotherapeutic strategy with azithromycin for preventing endometriosis progression.

Applications

Unspecified application

Species

Unspecified reactive species

Reina Sonehara,Tomoko Nakamura,Takehiko Takeda,Satoshi Kaseki,Tomomi Seki,Hideaki Tanaka,Atsushi Yabuki,Natsuki Miyake,Ayako Muraoka,Satoko Osuka,Akira Iwase,Hiroaki Kajiyama

Cells 13: PubMed38786035

2024

Long-Term Maintenance of Viable Human Endometrial Epithelial Cells to Analyze Estrogen and Progestin Effects.

Applications

Unspecified application

Species

Unspecified reactive species

Muhammad Assad Riaz,Franziska Louisa Kary,Alexandra Jensen,Felix Zeppernick,Ivo Meinhold-Heerlein,Lutz Konrad

MedComm 4:e433 PubMed38053815

2023

Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue-specific small extracellular vesicle network of breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Lesang Shen,Huanhuan Huang,Zichen Wei,Wuzhen Chen,Jiaxin Li,Yao Yao,Jun Zhou,Jian Liu,Shanshan Sun,Wenjie Xia,Ting Zhang,Xiuyan Yu,Jun Shen,Weilan Wang,Jingxin Jiang,Jian Huang,Ming Jiang,Chao Ni

Med (New York, N.Y.) 4:554-579.e9 PubMed37572651

2023

Organoid co-culture model of the human endometrium in a fully synthetic extracellular matrix enables the study of epithelial-stromal crosstalk.

Applications

Unspecified application

Species

Unspecified reactive species

Juan S Gnecco,Alexander Brown,Kira Buttrey,Clara Ives,Brittany A Goods,Lauren Baugh,Victor Hernandez-Gordillo,Megan Loring,Keith B Isaacson,Linda G Griffith

iScience 26:107357 PubMed37520702

2023

A delayed ovulation of progestin-primed ovarian stimulation (PPOS) by downregulating the LHCGR/PGR pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yating Xie,Wenya Guo,Xi Shen,Weina Yu,Yanping Kuang,Qiuju Chen,Hui Long,Qifeng Lyu,Li Wang

Journal of veterinary research 67:307-314 PubMed38143820

2023

Functional and morphological maturation of the full-sized and mini-pig corpus luteum by programmed cell death mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Ji-Hye Lee,Sang-Hwan Kim

Cancer medicine 12:3931-3951 PubMed36779496

2023

Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.

Applications

Unspecified application

Species

Unspecified reactive species

Mohammed Alradhi,Shuang Wen,Mohammed Safi,Abdullah Al-Danakh,Honglong Wang,Abdullah Shopit,Min Sun,Bo Fan,Xiancheng Li

International journal of molecular sciences 23: PubMed36499085

2022

Kelulut Honey Regulates Sex Steroid Receptors in a Polycystic Ovary Syndrome Rat Model.

Applications

Unspecified application

Species

Unspecified reactive species

Datu Agasi Mohd Kamal,Siti Fatimah Ibrahim,Azizah Ugusman,Mohd Helmy Mokhtar

Journal of gastrointestinal oncology 13:2197-2218 PubMed36388689

2022

Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yanzhuang Ke,Jieying Mai,Zhendong Liu,Yuyang Xu,Chunyi Zhao,Baochun Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com